The mRNA and protein levels of TBX1 were decreased (P < 0.05) (Figures 6(a) and 6(b)), and the TGF-β2 levels were raised in the CHD group (P < 0.05) (Figures 6(c) and 6(d)). The gene discussed is TBX1; the disease is coronary artery disorder.